Katja Schüz has more than 20 years of experience in the Pharmaceutical industry. She has worked with focus on Regulatory Affairs in the International / Emerging Markets and successfully contributed to various global Regulatory affairs projects and filings worldwide. Before returning to Merck KGaA, Darmstadt, Germany in June 2013 as director in Global Regulatory Affairs, she was heading Regulatory Affairs Product Strategy and CMC in H. Lundbeck A/S.
Renata Braga graduated in Pharmaceutical and Biochemistry Sciences and has 10 years’ experience in Regulatory Affairs, with a deep knowledge of Brazilian legislation. After working in Brazilian national and multinational pharmaceutical companies, she joined the Brazilian affiliate of Merck KGaA, Darmstadt, Germany in 2011. She is now responsible for the Biotech Division, coordinating the regulatory life cycle of products and giving regulatory support to internal and external clients.